BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity

Go back to BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity
(NYSE: CLVT) Delayed: 2.07 --0 (-0%)
Previous Close $2.07    52 Week High
Open $2.07    52 Week Low
Day High $2.07    P/E N/A 
Day Low $2.07    EPS
Volume 28,475